Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03816202 · ClinicalTrials.gov registry record
Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 100
- Enrollment target
NCT03816202: Completed study, sponsored by Integra LifeSciences Corporation.
NCT03816202 is a clinical trial that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03816202 has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The primary objective of this study is to retrospectively investigate the safety and efficacy of the Integra Sundt™ carotid shunt during endarterectomy procedures.
Primary Outcome
Number of participants with injury to the artery or cerebral ischemia secondary to shunt placement and removal
Interventions
- DEVICE Sundt carotid shunt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-04-25 |
| Est. Completion | 2019-08-27 |
What the finished NCT03816202 record still lists
NCT03816202 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Sundt carotid shunt is the first listed.
NCT03816202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03816202 about?
NCT03816202 is a clinical study titled "Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)". The primary objective of this study is to retrospectively investigate the safety and efficacy of the Integra Sundt™ carotid shunt during endarterectomy procedures.
What is the current status of trial NCT03816202?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-04-25. Estimated completion is 2019-08-27.
What interventions are being tested in trial NCT03816202?
The interventions under investigation include: Sundt carotid shunt (DEVICE).
Who is sponsoring clinical trial NCT03816202?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI